摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

cholest-5-en-3β-oxy-5-bromopentane | 335196-16-2

中文名称
——
中文别名
——
英文名称
cholest-5-en-3β-oxy-5-bromopentane
英文别名
(3S,8S,9S,10R,13R,14S,17R)-3-(5-bromopentoxy)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene
cholest-5-en-3β-oxy-5-bromopentane化学式
CAS
335196-16-2
化学式
C32H55BrO
mdl
——
分子量
535.692
InChiKey
HOXPBPSODWHTAJ-RWFZIKKDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    561.6±43.0 °C(Predicted)
  • 密度:
    1.08±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    10.9
  • 重原子数:
    34
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    4-dodecyloxy-4'-hydroxybiphenylcholest-5-en-3β-oxy-5-bromopentanepotassium carbonate 作用下, 以 丁酮 为溶剂, 生成 (3S,8S,9S,10R,13R,14S,17R)-3-[5-[4-(4-dodecoxyphenyl)phenoxy]pentoxy]-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene
    参考文献:
    名称:
    Smectic C Phases and Reentrant Behavior in Cholesterol Containing Dimer Liquid Crystals
    摘要:
    A series of dodecyloxybiphenylyl and cholesteryl group containing dimers with ethers as spacers have been prepared and their liquid crystalline properties were investigated as a function of spacer length. For short spacers SmA and SmC phases were observed with monolayer ordering. This is aparent from. polarization microscopy and temperature dependent X-ray measurements. With increasing spacer length a N*-phase gradually appears whose liquid crystalline range increases. For the dodecyl spacer no smectic phase is observed anymore. For the nonyl spacer reentrant behavior is found (N*-TGB-SmA-TGB-N*). Reentrant behavior, probably N*-TGB-N*, is also observed for a related compound with an ester spacer.
    DOI:
    10.1080/15421400490435035
  • 作为产物:
    描述:
    1-(cholest-5-en-3β-yloxy)pentan-5-ol 在 四溴化碳三苯基膦 作用下, 以 二氯甲烷 为溶剂, 反应 3.0h, 以97%的产率得到cholest-5-en-3β-oxy-5-bromopentane
    参考文献:
    名称:
    Structure of cholest-5-en-3β-oxy-5-bromopentane by single-crystal X-ray diffraction at 130 K
    摘要:
    Cholest-5-en-3 beta -oxy-5-bromopentane (1) and cholest-5-en-3 beta -oxy-11-bromoundecane (2), key precursors for the synthesis of novel cationic amphiphiles based on cholesterol, have been synthesized and characterized by H-1-NMR spectroscopy and X-ray crystallography. Thermal disorder and effect of length of the bromoalkyl segment on the crystal structure have been investigated. Possible molecular level explanation of the unusual alternating s-trans-gauche conformation of the bromopentyl side chain of (Ij has been presented. (C) 2001 Elsevier Science B.V. All rights reserved.
    DOI:
    10.1016/s0022-2860(00)00823-1
点击查看最新优质反应信息

文献信息

  • A Fluorescence Polarization Activity-Based Protein Profiling Assay in the Discovery of Potent, Selective Inhibitors for Human Nonlysosomal Glucosylceramidase
    作者:Daniël Lahav、Bing Liu、Richard J. B. H. N. van den Berg、Adrianus M. C. H. van den Nieuwendijk、Tom Wennekes、Amar T. Ghisaidoobe、Imogen Breen、Maria J. Ferraz、Chi-Lin Kuo、Liang Wu、Paul P. Geurink、Huib Ovaa、Gijsbert A. van der Marel、Mario van der Stelt、Rolf G. Boot、Gideon J. Davies、Johannes M. F. G. Aerts、Herman S. Overkleeft
    DOI:10.1021/jacs.7b07352
    日期:2017.10.11
    assessed on GBA2 selectivity offset against the other glucosylceramide metabolizing enzymes, glucosylceramide synthase (GCS), lysosomal glucosylceramidase (GBA), and the cytosolic retaining β-glucosidase, GBA3. Our work, yielding potent and selective GBA2 inhibitors, also provides a roadmap for the development of high-throughput assays for identifying retaining glycosidase inhibitors by FluoPol-ABPP
    人非溶酶体葡萄糖基神经酰胺酶(GBA2)是控制糖脂水平的几种酶之一,其活性与几种人类疾病状态相关。迫切需要设计或发现选择性的GBA2抑制剂作为化学工具和潜在的治疗剂。在这里,我们描述了基于荧光偏振活性的蛋白质谱分析(FluoPol-ABPP)测定法的发展,该测定法可从350多种亚氨基糖文库中快速鉴定GBA2抑制剂。基于FluoPol-ABPP筛选的线索生成聚焦库,并针对与其他葡糖神经酰胺代谢酶,葡糖神经酰胺合酶(GCS),溶酶体葡糖神经酰胺酶(GBA)和胞质保留β-葡糖苷酶GBA3的GBA2选择性偏移进行评估。我们的工作产生了有效的和选择性的GBA2抑制剂,
  • Structure of cholest-5-en-3β-oxy-5-bromopentane by single-crystal X-ray diffraction at 130 K
    作者:Yamuna Krishnan-Ghosh、R. Srinivasa Gopalan、G.U. Kulkarni、Santanu Bhattacharya
    DOI:10.1016/s0022-2860(00)00823-1
    日期:2001.1
    Cholest-5-en-3 beta -oxy-5-bromopentane (1) and cholest-5-en-3 beta -oxy-11-bromoundecane (2), key precursors for the synthesis of novel cationic amphiphiles based on cholesterol, have been synthesized and characterized by H-1-NMR spectroscopy and X-ray crystallography. Thermal disorder and effect of length of the bromoalkyl segment on the crystal structure have been investigated. Possible molecular level explanation of the unusual alternating s-trans-gauche conformation of the bromopentyl side chain of (Ij has been presented. (C) 2001 Elsevier Science B.V. All rights reserved.
  • Smectic C Phases and Reentrant Behavior in Cholesterol Containing Dimer Liquid Crystals
    作者:Antonius Marcelis、Arie Koudijs、Ernst Sudhölter
    DOI:10.1080/15421400490435035
    日期:2004.1
    A series of dodecyloxybiphenylyl and cholesteryl group containing dimers with ethers as spacers have been prepared and their liquid crystalline properties were investigated as a function of spacer length. For short spacers SmA and SmC phases were observed with monolayer ordering. This is aparent from. polarization microscopy and temperature dependent X-ray measurements. With increasing spacer length a N*-phase gradually appears whose liquid crystalline range increases. For the dodecyl spacer no smectic phase is observed anymore. For the nonyl spacer reentrant behavior is found (N*-TGB-SmA-TGB-N*). Reentrant behavior, probably N*-TGB-N*, is also observed for a related compound with an ester spacer.
查看更多